Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · IEX Real-Time Price · USD
21.74
-0.27 (-1.23%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.10 billion as of July 2, 2024. Its market cap has decreased by -21.69% in one year.
Market Cap
3.10B
Enterprise Value
2.21B
1-Year Change
-21.69%
Ranking
Category
Stock Price
$21.74
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.10B, an increase of 64.28%. That is a compound annual growth rate of 7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 3.14B | 5.84% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alvotech | 3.40B |
| Neogen | 3.39B |
| Corcept Therapeutics | 3.38B |
| Sotera Health Company | 3.36B |
| iRhythm Technologies | 3.35B |
| Arrowhead Pharmaceuticals | 3.23B |
| Oscar Health | 3.19B |
| Olink Holding AB (publ) | 3.17B |